Chapter
The Misinformation About Ivermectin and Hydroxychloroquine
2:43:26 - 2:48:12 (04:46)
The use of Ivermectin and Hydroxychloroquine for treating COVID-19 has been widely debated, but author and scientist Alex Wong explains the flaws in the early studies and how it does not effectively reduce the virus in humans.
Clips
Remdesivir targets the virus itself, whereas Hydroxychloroquine can block the endocytic pathway that the virus needs to enter cells.
2:43:26 - 2:44:31 (01:05)
Summary
Remdesivir targets the virus itself, whereas Hydroxychloroquine can block the endocytic pathway that the virus needs to enter cells. However, studies on Hydroxychloroquine are limited to kidney cells in cultures.
ChapterThe Misinformation About Ivermectin and Hydroxychloroquine
Episode#216 – Vincent Racaniello: Viruses and Vaccines
PodcastLex Fridman Podcast
The discussion explains why hydroxychloroquine is not effective as an antiviral and the confusion surrounding ivermectin as a treatment for COVID-19.
2:44:32 - 2:46:18 (01:46)
Summary
The discussion explains why hydroxychloroquine is not effective as an antiviral and the confusion surrounding ivermectin as a treatment for COVID-19. Additionally, it highlights that antivirals for COVID-19 are required in most cases when an individual cannot breathe and requires hospitalization.
ChapterThe Misinformation About Ivermectin and Hydroxychloroquine
Episode#216 – Vincent Racaniello: Viruses and Vaccines
PodcastLex Fridman Podcast
The new approach for individuals in high risk groups is to receive monoclonal antibodies at the first sign of COVID-19 symptoms to inhibit the virus, instead of waiting until hospitalization, when it may be too late for treatment.
2:46:18 - 2:48:12 (01:53)
Summary
The new approach for individuals in high risk groups is to receive monoclonal antibodies at the first sign of COVID-19 symptoms to inhibit the virus, instead of waiting until hospitalization, when it may be too late for treatment.